A study of proteins involved in the inflammation and pain associated with arthritis of the knee.

Not Applicable

• Conditions: Rhuematoid arthritis; Gout; Osteoarthritis; Psoriatic arthritis; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12611000048987
• Lead Sponsor: Royal Perth Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-01-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 95

Inclusion Criteria

OA of the knee based on ACR clinical criteria
Active gout of the knee
RA meeting ACR criteria
PsA meeting CASPAR criteria

Exclusion Criteria

Contraindication or unwillingness to undergo an US scan
Contraindication or unwillingness to undergo arthrocentesis
(Including an INR> 2)
Diagnosis of septic arthritis, Paget’s disease, articular fracture, ochronosis, acromegaly, haemochromatosis, Wilson’s disease, primary osteochondrosis
Injury to the study knee within 6 months of the study start
knee joint replacement (partial or total); osteotomy of the studied joint; with arthroscopy of the studied joint made within 1 year of the study start
With an intra articular injection of steroids made within 4 weeks and/or intra articular injection of radionuclide made with 3 months prior to study entry

Study & Design

• Study Type: Observational
• Study Design: Not specified